Similar articles

Abstract: Gene therapies have been applied to the treatment of cardiovascular disease, but their use is limited by the need to deliver them to the right target. We have employed targeted contrast ultrasound-mediated gene transfection (TCUMGT) via ultrasound-targeted microbubble destruction (UTMD) to transfer therapeutic genes to specific anatomic and pathological targets. Phospholipid microbubbles (MBs) with pcDNA_3.1-human vascular endothelial growth factor 165 (pcDNA_3.1-hVEGF₁₆₅) plasmids targeted to p-selectin (MB+P+VEGFp) were created by conjugating monoclonal antibodies against p-selectin to the lipid shell. These microbubbles were divided into four groups: microbubble only (MB), microbubble+p-selectin (MB+P), microbubble+pcDNA_3.1-hVEGF₁₆₅ plasmid (MB+VEGFp), and microbubble+ p-selectin+pcDNA_3.1-hVEGF₁₆₅ plasmid (MB+P+VEGFp). The reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) results showed that the VEGF gene was successfully transfected by TCUMGT and the efficiency is increased with p-selectin targeting moiety. UTMD-mediated delivery of VEGF increased myocardial vascular density and improved cardiac function, and MB+P+VEGFp delivery showed greater improvement than MB+VEGFp. This study drew support from TCUGMT technology and took advantage of targeted ultrasound contrast agent to identify ischemic myocardium, release pcDNA_3.1-hVEGF₁₆₅ recombinant plasmid, and improve the myocardial microenvironment, so promoting the restoration of myocardial function.

超声靶向击碎微泡技术介导P-选择素靶向阳离子超声微泡改善人血管内皮生长因子165基因转染缺血心肌的实验性研究

[1]Bekeredjian R, Grayburn PA, Shohet RV, 2005. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol, 45(3):329-335.

[2]Christiansen JP, French BA, Klibanov AL, et al., 2003. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol, 29(12):1759-1767.

[3]Douvaras P, Antonatos DG, Kekou K, et al., 2009. Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction. Cardiology, 114(1):11-18.

[4]Everaert BR, Bergwerf I, de Vocht N, et al., 2012. Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing. BMC Biotechnol, 12:93.

[5]Ferrante EA, Pickard JE, Rychak J, et al., 2009. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release, 140(2):100-107.

[6]Ferrara K, Pollard R, Borden M, 2007. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng, 9:415-447.

[7]Fujii H, Li SH, Wu J, et al., 2011. Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. Eur Heart J, 32(16):2075-2084.

[8]Gerhardt H, 2008. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis, 4(4):241-246.

[9]Hoeben A, Landuyt B, Highley MS, et al., 2004. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev, 56(4):549-580.

[10]Hu DX, Liu XB, Song WC, et al., 2016. Roles of SIRT3 in heart failure: from bench to bedside. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 17(11):821-830.

[11]Jessup M, Greenberg B, Mancini D, et al., 2011. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID):a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca²⁺-ATPase in patients with advanced heart failure. Circulation, 124(3):304-313.

[12]Kelly S, Bombardieri M, Humby F, et al., 2015. Angiogenic gene expression and vascular density are reflected in ultrasonographic features of synovitis in early rheumatoid arthritis: an observational study. Arthritis Res Ther, 17:58.

[13]Leung K, 2004. Microbubbles Coated with Antibody to Intracellular Adhesion Molecule-1. National Center for Biotechnology Information, Bethesda, USA.

[14]Lindner JR, Song J, Christiansen J, et al., 2001. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation, 104(17):2107-2112.

[15]Liu J, Zhang P, Liu P, et al., 2012. Endothelial adhesion of targeted microbubbles in both small and great vessels using ultrasound radiation force. Mol Imaging, 11(1):58-66.

[16]Sirsi SR, Borden MA, 2012. Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics, 2(12):1208-1222.

[17]Sun L, Huang CW, Wu J, et al., 2013. The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium. Biomaterials, 34(8):2107-2116.

[18]Sutton MGS, Sharpe N, 2000. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation, 101(25):2981-2988.

[19]Sutton MSJ, Pfeffer MA, Moye L, et al., 1997. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the survival and ventricular enlargement (SAVE) trial. Circulation, 96(10):3294-3299.

[20]Takalkar AM, Klibanov AL, Rychak JJ, et al., 2004. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release, 96(3):473-482.

[21]Unger E, Porter T, Lindner J, et al., 2014. Cardiovascular drug delivery with ultrasound and microbubbles. Adv Drug Deliv Rev, 72:110-126.

[22]Xie A, Belcik T, Qi Y, et al., 2012. Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles. JACC Cardiovasc Imaging, 5(12):1253-1262.

[23]Yau TM, Fung K, Weisel RD, et al., 2001. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation, 104(S1):I-218-I-222.

[24]Yu Q, Fang WY, Zhu N, et al., 2015. Beneficial effects of intramyocardial mesenchymal stem cells and VEGF₁₆₅ plasmid injection in rats with furazolidone induced dilated cardiomyopathy. J Cell Mol Med, 19(8):1868-1876.

[25]Zhao ZQ, Corvera JS, Halkos ME, et al., 2003. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol, 285(2):H579-H588.